Editors Choice

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

In a startling disclosure at the EU COVI Hearings in Brussels on the 10th of October 2022, Janine Small admitted in response to a question posed by Dutch MEP Robert Roos that the Pfizer mRNA vaccine was never tested or shown before its release, to impact the transmission of the SARS-NCOV2 virus. In other words, whether the vaccine did, prevent transmission of Covid from one person to another. You can follow the entire hearing via the EU Media Center or watch the embedded video below.

Depending on your location this video may take some time to load. You can use the link above to load the video in a separate browser window.

In response to the MEP’s question, if the Pfizer mRNA vaccine had ever been tested before its release to the general public on its ability to prevent Covid transmission, Ms. Small responded by admitting it hadn’t. If the comment is accurate, we must determine how this disclosure impacts trust in scientific exchange and public health.

“Regarding the question around did we know about stopping immunization before it entered the market…No., We have to really move at the speed of science to really understand what is taking place in the market.”

Small then continued to justify her answer and you can watch her full response above by forwarding the video to the timestamp of 15.31.

Roos then immediately took to social media at the conclusion of the hearing, questioning on what basis governments within the EU had justified Covid vaccine passports if the vaccine was unable to affect the transmissibility of the virus. The main reason that people were vaccinating to protect each other was based on a fiction.

From a medical perspective, this admission matters tremendously. If the vaccines offered little to no communal benefit of protection against the transmission of the virus, the justification for, for instance, vaccinating school children is questionable. The known risks of the vaccines and listed SAEs far outweigh the benefits to this population.

By extension, the same logic can be applied to young and healthy adults not at risk from any comorbidities. It would appear that the argument offered by Governments and Health bodies for the public to act in the interests of protecting their fellow citizens was nothing less than disingenuous. A fabrication designed to coerce public compliance, exposing yet another fundamental flaw in the global management of the Covid pandemic.

The need for these products in the high-risk population is clear. Covid can kill and it is critical that public health institutions enjoy the trust of the public for the health system to function effectively. Otherwise, communication breaks down, creating chaos. To discover more truths and fictions relating to mRNA vaccines, read this piece.

Robert Turner, Founding Editor

Robert is a Founder of Medika Life. He is a published author and owner of MedKoin Healthcare Solutions. He lives between the Philippines and the UK. and is an outspoken advocate for human rights. Access to basic healthcare and eradicating racial and gender bias in medicine are key motivators behind the Medika website and reflect Robert's passion for accessible medical care globally.

Recent Posts

India: The Growing Focal Point for Health Innovation

India is no longer simply a market to watch. It is a nation shaping the…

3 hours ago

GLP‑1 Medications in Later Life: Why the “Miracle Shot” Needs a Senior‑Specific Safety Lens

When GLP-1 medications like semaglutide began to gain attention, many people saw them as a…

3 hours ago

Why Sophisticated Investors Really Care about Health in Africa

At the end of last year, I was lucky enough to get an insight into…

3 hours ago

Medical Innovation Still Matters—Even When the System Makes It Hard

Healthcare today is increasingly shaped by actuarial logic rather than human outcomes. Coverage decisions are…

3 days ago

Who Will Direct Patient Care: Physicians or Technocrats?

Not long ago, a physician’s most powerful instrument was not a machine, an algorithm, or…

3 days ago

GLP‑1 Medications in Later Life: Why the “Miracle Shot” Needs a Senior‑Specific Safety Lens

When GLP-1 medications like semaglutide began to gain attention, many people saw them as a…

3 days ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More